Nifty Pharma joins markets bullish bandwagon, index surges; Divi's Lab, Lupin, Cipla lift the performance

Divi's Laboratories performed well surging by 0.76% at Rs3,813.00 per piece.

Apr 27, 2021 11:04 IST India Infoline News Service

Bull-vs-Bear
After the bearish tone in previous trading session, Nifty Pharma joins the bull bandwagon on Tuesday. The government's announcement to open up vaccination for all above 18 from 1st May steps in the right direction for market perspective.

Somehow, the Index been under some pressure amidst rising Covid-19 cases in India resulting in restrictions in certain States.

23 states in India have announced that they will offer free vaccines to all those who are eligible for vaccination. States like Maharashtra, Karnataka, Kerala, Rajasthan, Gujarat, Chhattisgarh, Delhi, are on the list. The free vaccination will be available at government hospitals in all these states only. They will not be free in private hospitals.

On Tuesday, at around 11:25 AM, Nifty Pharma performs at 13,233.50 up by 85.35 points or 0.23%. The index has touched an intraday high of 13,279.25 and intraday low of 13,180.95 during early trading session.

Somehow, the Index been under some pressure amidst rising Covid-19 cases in India resulting in restrictions in certain States.

On the index, Divi's Laboratories performed well surging by 0.76% at Rs3,813.00 per piece.

Aurobindo Pharma and Lupin also traded higher while Dr Reddy's, Sun Pharma and Cipla were also marginally higher.

Alkem Laboratories shed 0.40% while Torrent Pharma was down 0.20%.

Biocon was also trading in the red by 0.5% at Rs393.55 per piece.

Cadila Healthcare was the top bear on the index dragging the sector most by tumbling 1.47%.
 
In last 24 hours, India registers 3,52,991 new covid cases while country's cumulative vaccination coverage exceeds 14.19 cr as the Largest Vaccination Drive completes 100 days.

Related Story

Open Free Demat Account (Rs699)